Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cryolife (NY: CRY )

24.44 USD -0.11 (-0.45%)
Official Closing Price Updated: 7:00 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Cryolife

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2020 Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2020 financial results will be released on... 
From PR Newswire
CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020
Webcast to Include Presentation by Steering Committee Co-Chair John H. Alexander, MD, MHS Highlighting Clinical Trial Progress 
From PR Newswire
CryoLife Reports Third Quarter 2020 Financial Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 third quarter financial results will be released on Wednesday, November... 
From PR Newswire
CryoLife to Present at the 18th Annual Morgan Stanley Global Healthcare Conference
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 18th Annual Morgan Stanley Global... 
From PR Newswire
CryoLife Acquires Ascyrus Medical
Conference Call and Webcast Today, September 2, 2020 at 5:00 pm ET 
From PR Newswire
CryoLife to Participate in Upcoming Virtual Investor Conferences
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences. 
From PR Newswire
CryoLife Reports Second Quarter 2020 Financial Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2020 Second Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 second quarter financial results will be released on Thursday, July 30,... 
From PR Newswire
CryoLife Announces Pricing of $100 Million Convertible Senior Notes Offering
CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced the pricing of $100 million aggregate principal... 
From PR Newswire
CryoLife Announces Offering of Convertible Senior Notes Due 2025
CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it intends to offer, subject to market... 
From PR Newswire
NYSE: CRY Investor Notice: Investigation over Potential Wrongdoing at CryoLife, Inc.
San Diego, CA -- (SBWIRE) -- 06/16/2020 -- An investigation on behalf of investors in CryoLife, Inc. (NYSE: CRY) shares over potential wrongdoing at CryoLife, Inc. was announced. 
From SBWire - Latest Press Releases
CryoLife Initiates Enrollment in PROACT Xa Clinical Trial
Study Designed to Evaluate the Use of Apixaban in On-X Aortic Valve Patients 
From PR Newswire
CryoLife Reports First Quarter 2020 Financial Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2020 First Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 first quarter financial results will be released on Thursday, April 30,... 
From PR Newswire
CryoLife, Inc. (NYSE: CRY) Shareholder Notice: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 04/15/2020 -- An investigation for investors in CryoLife, Inc. (NYSE: CRY) shares over potential securities laws violations by CryoLife, Inc. was announced. 
From SBWire - Latest Press Releases
CryoLife Provides Business Update in Response to COVID-19 Pandemic
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has taken multiple steps to focus on the health and welfare of its employees,... 
From PR Newswire
CryoLife Receives CE Mark for E-vita Open NEO™ Hybrid Stent Graft
Newest Hybrid Stent Graft Offering Enhances Ease-of-Use 
From PR Newswire
CryoLife Receives CE Mark for On-X® Ascending Aortic Prosthesis
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the On-X Ascending Aortic Prosthesis (AAP), allowing... 
From PR Newswire
CryoLife Reports Fourth Quarter and Full Year 2019 Financial Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2019 Fourth Quarter and Year-end Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 fourth quarter and year-end financial results will be released on... 
From PR Newswire
CryoLife Receives FDA Authorization to Commence PROACT Xa Clinical Trial
Study Designed to Evaluate the Use of Apixaban in On-X Aortic Valve Patients 
From PR Newswire
CryoLife and Misonix Enter Into Distribution Agreement for NeoPatch
CryoLife Will Supply NeoPatch, a Chorioamniotic Membrane Tissue, to Misonix 
From PR Newswire
CryoLife Receives CE Mark for E-nya Thoracic Stent Graft
Product Launch Anticipated in the First Quarter 2020 
From PR Newswire
CryoLife Receives CE Mark for E-nside Thoraco-abdominal Stent Graft
First Off-the-Shelf Thoraco-abdominal Stent Graft with Pre-Cannulated Inner Branch Technology 
From PR Newswire
CryoLife Reports Third Quarter 2019 Financial Results
From PR Newswire
CryoLife Announces Release Date and Teleconference Call Details for 2019 Third Quarter Financial Results
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 third quarter financial results will be released on Wednesday, October... 
From PR Newswire
Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund
The new fund has already received a commitment from an anchor investor, Vincent Tchenguiz 
From PR Newswire
CryoLife to Participate in the Deutsche Bank 27th Annual Leveraged Finance Conference
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in a fireside chat with analysts and investors at the... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.